Market News

Clough Capital Partners LP Has Boosted Its Intra Cellular Therapies (ITCI) Holding by $576,800; Market Value Rose; Md Sass Investors Services Has Boosted Norwegian Cruise Line Hldgs (NCLH) Holding by $15.13 Million as Market Value Declined

Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) Logo

Charles Clough increased its stake in Intra Cellular Therapies Inc (ITCI) by 6.25% based on its latest 2017Q4 regulatory filing with the SEC. Clough Capital Partners LP bought 41,200 shares as the company’s stock rose 32.12% while stock markets declined. The hedge fund run by Charles Clough held 699,950 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $10.14 million, up from 658,750 at the end of the previous reported quarter. Clough Capital Partners LP who had been investing in Intra Cellular Therapies Inc for a number of months, seems to be bullish on the $1.21 billion market cap company. The stock increased 0.59% or $0.13 during the last trading session, reaching $22.07. About 243,172 shares traded. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) has risen 27.96% since May 18, 2017 and is uptrending. It has outperformed by 16.41% the S&P500.

Martin D. Sass increased its stake in Norwegian Cruise Line Hldgs (NCLH) by 66.6% based on its latest 2017Q4 regulatory filing with the SEC. Md Sass Investors Services Inc bought 285,390 shares as the company’s stock declined 2.15% with the market. The hedge fund run by Martin D. Sass held 713,885 shares of the marine transportation company at the end of 2017Q4, valued at $38.02M, up from 428,495 at the end of the previous reported quarter. Md Sass Investors Services Inc who had been investing in Norwegian Cruise Line Hldgs for a number of months, seems to be bullish on the $11.79B market cap company. The stock decreased 0.02% or $0.01 during the last trading session, reaching $52.49. About 2.05M shares traded. Norwegian Cruise Line Holdings Ltd. (NASDAQ:NCLH) has risen 3.63% since May 18, 2017 and is uptrending. It has underperformed by 7.92% the S&P500.

Md Sass Investors Services Inc, which manages about $1.91B and $1.12 billion US Long portfolio, decreased its stake in Delta Air Lines Inc Del (NYSE:DAL) by 217,460 shares to 706,837 shares, valued at $39.59M in 2017Q4, according to the filing. It also reduced its holding in Royal Caribbean Cruises Ltd (NYSE:RCL) by 4,100 shares in the quarter, leaving it with 24,900 shares, and cut its stake in Wen Hldg Inc.

Since March 2, 2018, it had 0 insider buys, and 2 insider sales for $1.09 billion activity.

More notable recent Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) news were published by: Prnewswire.com which released: “Morning Technical Insight on These Resorts & Casinos Stocks — Melco Resorts & Entertainment, MGM Resorts …” on May 04, 2018, also Globenewswire.com with their article: “Consolidated Research: 2018 Summary Expectations for Norwegian Cruise Line, Integrated Device Technology, Align …” published on April 20, 2018, Globenewswire.com published: “Norwegian Cruise Line Holdings to Hold Conference Call on First Quarter 2018 Financial Results” on April 25, 2018. More interesting news about Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) were released by: Globenewswire.com and their article: “Norwegian Cruise Line Holdings Releases 2017 Stewardship Report” published on April 23, 2018 as well as Investorplace.com‘s news article titled: “Carnival Corp Stock Looks as If It Is Headed for Rocky Seas” with publication date: May 02, 2018.

Investors sentiment decreased to 1.34 in Q4 2017. Its down 0.48, from 1.82 in 2017Q3. It is negative, as 36 investors sold NCLH shares while 107 reduced holdings. 79 funds opened positions while 112 raised stakes. 202.66 million shares or 0.99% more from 200.67 million shares in 2017Q3 were reported. The California-based First Republic has invested 0% in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH). Cap Intll owns 10.37 million shares or 0.62% of their US portfolio. 35,244 were reported by Virtus Investment Advisers. Marsico Cap Mngmt Ltd Limited Liability Company reported 0.5% stake. Guardian invested in 1.12% or 1.49M shares. Blackrock accumulated 11.09 million shares. Washington Trust Fincl Bank accumulated 0.01% or 896 shares. Proshare Ltd Liability accumulated 46,951 shares or 0.02% of the stock. Guardian Life Of America holds 578 shares or 0.01% of its portfolio. 33,500 are held by Andra Ap. Gotham Asset Management Ltd Co accumulated 0.01% or 15,095 shares. Aviva Public Limited Company holds 95,180 shares. Livforsakringsbolaget Skandia Omsesidigt has 0.02% invested in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) for 3,000 shares. Pnc Financial Services Gp invested in 20,028 shares or 0% of the stock. Moreover, Westpac Corp has 0.02% invested in Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) for 13,845 shares.

Among 22 analysts covering Norwegian Cruise Line (NASDAQ:NCLH), 16 have Buy rating, 1 Sell and 5 Hold. Therefore 73% are positive. Norwegian Cruise Line had 59 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) has “Equal-Weight” rating given on Friday, November 10 by Morgan Stanley. The rating was initiated by Wolfe Research on Wednesday, November 18 with “Peer Perform”. Tigress Financial maintained the stock with “Buy” rating in Monday, May 7 report. The firm has “Buy” rating by Citigroup given on Tuesday, September 13. Deutsche Bank maintained Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH) rating on Friday, February 23. Deutsche Bank has “Hold” rating and $66 target. The firm earned “Buy” rating on Friday, February 19 by Buckingham Research. The stock has “Buy” rating by Zacks on Monday, August 10. On Wednesday, August 5 the stock rating was maintained by Stifel Nicolaus with “Buy”. The firm has “Neutral” rating given on Friday, October 14 by Wedbush. As per Wednesday, November 23, the company rating was downgraded by Bernstein.

Investors sentiment decreased to 1.46 in Q4 2017. Its down 1.31, from 2.77 in 2017Q3. It is negative, as 21 investors sold ITCI shares while 27 reduced holdings. 21 funds opened positions while 49 raised stakes. 37.43 million shares or 5.83% less from 39.74 million shares in 2017Q3 were reported. 42 were accumulated by Hanseatic. Alpine Woods Invsts Lc invested 0.02% in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Dimensional Fund Advisors LP holds 1.28M shares. First Midwest State Bank Tru Division reported 187,120 shares. Stifel Fincl has 14,400 shares. Tocqueville Asset Management LP reported 0% of its portfolio in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Baker Bros Advsr Ltd Partnership holds 0.08% of its portfolio in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) for 609,166 shares. Legal General Group Public Limited Com holds 18,590 shares. Premier Asset Management Limited Liability Corp holds 0.05% in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) or 16,826 shares. Keybank Natl Association Oh invested 0% in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Gsa Capital Prtnrs Ltd Liability Partnership holds 0.1% in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) or 111,100 shares. New York-based Metropolitan Life Ins Ny has invested 0% in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Tiaa Cref Inv Mngmt holds 174,620 shares or 0% of its portfolio. 53,932 are owned by Cubist Systematic Strategies Lc. Us Savings Bank De holds 0% or 1,876 shares in its portfolio.

More important recent Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) news were published by: Gurufocus.com which released: “Stanley Druckenmiller’s Top 5 Buys in 1st Quarter” on May 17, 2018, also Nasdaq.com published article titled: “Intra-Cellular Therapies Reports First Quarter 2018 Financial Results and Provides Corporate Update”, Nasdaq.com published: “Intra-Cellular Therapies Presents Data on ITI-214 at the 2018 American Academy of Neurology Annual Meeting” on April 26, 2018. More interesting news about Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) was released by: Benzinga.com and their article: “Benzinga’s Daily Biotech Pulse: Intra-cellular Moves On Poster Presentation, Earnings Beats From Vertex, Exact …” with publication date: April 27, 2018.

Since December 11, 2017, it had 0 buys, and 10 selling transactions for $2.07 million activity. $17,394 worth of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) shares were sold by Davis Robert E. $69,179 worth of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) was sold by Halstead Michael on Wednesday, January 3. $105,630 worth of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) was sold by LERNER RICHARD A. Vanover Kimberly E. also sold $13,479 worth of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) on Monday, January 8. Mates Sharon had sold 11,257 shares worth $192,270.

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *